The FDA officially approved remdesivir corona treatment, the first

The Centers for Disease Control and Prevention (CDC) will supply “mdesivir,” which has been specially imported as a treatment for the new coronavirus infection (Corona 19), starting on day 1. Remdesivir will be administered to seriously ill patients who have pneumonia and need oxygen therapy. Image shows Remdesivir. (Provided by Seoul National University Bundang Hospital) 2020.7.1 / News 1

The United States Food and Drug Administration (FDA) has officially approved remdesivir, made by Gilead, as a treatment for COVID-19. Consequently, Gilead’s share price has skyrocketed more than 4% in overtime trading.

The FDA officially approved remdesivir, an antiviral treatment, as a treatment for Corona 19 on the 22nd (local time). When the news broke, Gilead’s stock price rose 4.2% in overtime to $ 63.18.

Remdesivir is the first time it has been officially approved by the FDA as a treatment for Corona 19. Previously, the FDA approved for emergency use, but did not give official approval.

Remdesivir was originally developed to treat Ebola and has attracted attention as a treatment for Corona 19, as it appears to be effective against Corona 19. Remdesivir was one of the treatments President Trump received when he was hospitalized. Clinical trials have shown that remdesivir has little effect on mortality, but it can speed up patient recovery.

In a clinical trial, a study found that remdesivir shortened the recovery period of Corona19 patients by an average of 5 days. According to Reuters, 1,062 COVID-19 patients participated in the clinical trial for 29 days and the results were published in the New England Journal of Medicine.

In this study, when remdesivir was administered with oxygen therapy, the recovery period was shortened to 7 days.

However, experts say it does not reduce the death rate. Clinical trials from the World Health Organization (WHO) have shown that remdesivir has no effect on reducing mortality.

However, the reason why the FDA officially approved it as a treatment is discussed because it can shorten the recovery period.

Daniel Oday, CEO of Gilead, said: “The FDA, which has a reputation for being strict, has approved remdesivir as a treatment for COVID-19. This reflects the efforts of the government, pharmaceutical companies and clinical trial participants.”

(Seoul = News 1)